Vaginal Slings Market - By Product (Transobturator, Tension-free Vaginal Tape, Mini-Slings), Incontinence type (Stress, Urge, Mixed), Type (Midurethral, Traditional), End-use (Hospitals, Clinics, ASC) – Global Forecast, 2024 – 2032

Vaginal Slings Market - By Product (Transobturator, Tension-free Vaginal Tape, Mini-Slings), Incontinence type (Stress, Urge, Mixed), Type (Midurethral, Traditional), End-use (Hospitals, Clinics, ASC) – Global Forecast, 2024 – 2032

Vaginal Slings Market Size

Vaginal Slings Market size was valued at over USD 1.6 billion in 2023 and is estimated to expand at 9% CAGR from 2024 to 2032 attributed to the rising prevalence of stress urinary incontinence (SUI), and the strong demand for minimally invasive procedures. As per reports, around 1 in 3 people who were assigned female at birth (AFAB) will experience SUI at some point. This growing disease burden along with the aging global population will drive the market growth. 
 

Continuous advancements in surgical techniques and materials used in vaginal sling treatments are helping to improve efficacy, safety, and overall patient outcomes. The integration of technological innovations is serving as a compelling factor, attracting both healthcare providers and patients, thereby contributing to the product uptake.

However, the high costs associated with surgical procedures and equipment can limit accessibility for patients, particularly in low-income regions. Regulatory challenges and complicated approval processes can delay the introduction of new products, while different fee structures in diverse regions can make market expansion more difficult. Limited awareness and social stigma regarding urinary incontinence and its treatment is further preventing patients from seeking medical help. 
 

Vaginal Slings Market Trends

The continuous technological advancements in surgical techniques, rising emphasis on personalized medicine, and surging demand for integrated AI in healthcare delivery will favor the market growth. Lately, a transition towards patient-centered treatment has been observed in the healthcare landscape. Physicians are placing focus on recognizing and meeting the unique requirements and preferences of patients having vaginal sling operations. This has made way for shared decision-making, informed consent, and continual communication to improve patient satisfaction. 
 

Vaginal Slings Market Analysis

Based on product, the industry size from the transobturator slings segment generated USD 665.5 million in 2023 and will witness 8.5% CAGR through 2032 backed by their minimally invasive nature. This technique includes placing the sling through small incisions in the groin, further reducing the need for larger abdominal incisions. Patients often prefer minimally invasive procedures over traditional open surgical techniques due to their associated benefits, including quicker recovery times, reduced postoperative discomfort, and potentially lower complication rates.
 

Based on incontinence type, the vaginal slings market from the stress incontinence segment recorded USD 677.5 million in 2023 and is expected to reach over USD 1.4 billion by 2032.  The aging population is more susceptible to SUI due to changes in pelvic anatomy and muscle tone. As a result, the global increase in the number of elderly individuals is contributing to the rising prevalence of stress incontinence, driving the demand for effective treatments, such as vaginal slings. As per UN. Org, from 2015 to 2050, the proportion of the population aged over 60 years is projected to nearly double, increasing from 12% to 22%.
 

Based on type, the market size from the midurethral sling segment is likely to generate over USD 2.6 billion by 2032. These slings provide excellent efficiency rates in treating stress urine incontinence. Various clinical studies and real-world data have confirmed the usefulness of these slings in improving the continence care and quality of life of patients, making them preferrable among patients and healthcare professional. These methods usually use tiny incisions for shorter recovery durations, less postoperative discomfort, and faster return to regular activities than standard open surgical approaches. The rising focus on enhancing patient acceptability is fostering the segment growth.  
 

Based on end-use, the vaginal slings market from the hospitals segment will account for over USD 1.8 billion in revenue by 2032. Hospitals are increasingly adopting minimally invasive surgical techniques to offer shorter hospital stays, reduced recovery times, and lower overall healthcare costs. This aligns with the vast shift towards healthcare and less invasive interventions.
Hospitals are also investing in training and education programs to ensure that physicians, including surgeons and nursing staff, are proficient in performing vaginal sling procedures.

North America vaginal slings market size was over USD 385 million in 2023 and is predicted to witness 8.6% CAGR from 2024 to 2032. Ongoing advancements in surgical techniques, materials, and design of vaginal slings are contributing to the higher adoption and implementation of latest and most advanced treatment options.  The growing demand from patients for effective and sophisticated solutions, such as vaginal slings, is driving healthcare providers to offer these procedures, adding to the regional product uptake.
 

Vaginal Slings Market Share

The vaginal slings industry is competitive in nature, comprising several large multinationals as well as small and mid-sized companies competing in the market. The development and launch of novel advanced products based on different technologies is one of the key strategies employed these firms. They are also indulging in partnership ventures and R&D investments to widen their global presence.
 

Vaginal Slings Market Companies

Some of the eminent market participants operating in the vaginal slings industry include

• A.M.I. GmbH
• UroCure
• B. Braun
• Melsungen AG
• Betatech Medical
• Boston Scientific Corporation
• Caldera Medical
• Coloplast Corp
• Cousin Surgery
• Johnson & Johnson Services, Inc.
• Lotus Surgicals
• Neomedic International
• Promedon S.A. 
   

Vaginal Slings Industry News

• In January 2024, UroCure and LiNA Medical USA launched two new surgical solutions for female stress urinary incontinence nationwide.
   
• In March 2024, the FDA granted its 510(k) clearance to a vaginal insert, Y?ni.Fit Bladder Support, for adult patients suffering from urine leakage caused by stress urinary incontinence (SUI).
   

Vaginal slings market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Transobturator slings
• Tension-free vaginal tape slings
• Mini slings

Market, By Incontinence Type

• Stress incontinence
• Urge incontinence
• Mixed incontinence

Market, By Type

• Midurethral slings
• Traditional slings

Market, By End-use

• Hospitals
• Clinics
• Ambulatory surgical centers

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa